Andrew Stephenson, M.D.

Andrew Stephenson, MD, is a Staff physician at Cleveland Clinic's Glickman Urological and Kidney Institute on the main campus. Dr. Stephenson completed his urology training at McGill University in Montreal, Canada, followed by fellowship training in urologic oncology at Memorial Sloan-Kettering Cancer Center in New York. He joined Cleveland Clinic in 2006.

Dr. Stephenson’s clinical and research interests are in the treatment of patients with cancers of prostate, bladder and testis. He has published over 40 articles in peer-reviewed journals since 2002 on issues related to prostate, bladder and testicular cancer, many of which have received national and international mainstream media attention. He has been invited to speak at several major international oncology conferences on these subjects.

Dr. Stephenson has received numerous awards from organizations such as the Prostate Cancer Foundation, American Society of Clinical Oncology, and Society of Urologic Oncology. He was recently named as one of the Best Doctors in America.

Dr. Stephenson's research focus is on the development of prognostic statistical models called nomograms. These prognostic models provide accurate predictions of treatment outcome for prostate cancer and are widely used for patient counseling. He is the principal investigator of a large national randomized trial in advanced prostate cancer, and is a reviewer for several major oncology and urology journals such as Cancer, Nature and Journal of Urology.

For patients with prostate cancer, Dr. Stephenson performs both nerve-sparing open radical prostatectomy and robotic-assisted laparoscopic prostatectomy. The decision to perform either open or robotic prostatectomy is tailored to the specifics of each patient’s cancer and his personal preferences. For patients with bladder cancer, Dr. Stephenson also performs nerve-sparing radical cystectomy, extended pelvic lymphadenectomy, and orthotopic urinary diversion (neobladder or Studer) for both men and women. For select patients with testicular cancer, Dr. Stephenson performs nerve-sparing retroperitoneal lymph node dissection.

Dr. Stephenson’s family roots are in Northeast Ohio. He is married with four children.

Royal College of Physicians & Surgeons of Canada

• Development of several nomograms for prostate cancer. These prognostic models provide accurate predictions of treatment outcome for prostate cancer and are widely used for the counseling of patients with localized and advanced prostate cancer.

• 2007 — Selected: Best Doctors in America, 2007-2008
• 2006 — Merit Award, American Society of Clinical Oncology
• 2005 — Prostate Cancer Foundation Award, Society of Urologic Oncology
• 2005 — Merit Award, American Society of Clinical Oncology
• 2004 — Merit Award, American Society of Clinical Oncology
• 2003 — Scholar-In-Training Award, American Association for Cancer Research
• 2003 — Merit Award, American Society of Clinical Oncology
• 2003 — Frank McGill Travel Fellowship, McGill University Health Centre Foundation
• 2002 — Post-Resident Research Scholar, American Foundation for Urologic Disease
• 1993 — Phi Beta Kappa, Eta of New York Chapter, Colgate University

• Society of Urologic Oncology
• American Urological Association
• American Society of Clinical Oncology
• American College of Surgeons
• Canadian Urological Association